Intravitreal Aflibercept (IVT-AFL) for Diabetic Macular Edema (DME): 3 Year Data from VIVID-DME and VISTA-DME

被引：0
|
作者：
Staurenghi, G.
Metzig, C.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷
关键词：
D O I：
10.1111/j.1755-3768.2015.0600
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
ABS15-0600
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results
    Marcus, Dennis M.
    Frazier, Heather
    Rex, Priscila
    Marcus, William
    Starnes, Davis
    Walia, Harveen
    Singh, Harinderjit
    Lalane, Robert
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [42] Sustained Diabetic Retinopathy Severity Improvement with Intravitreal Aflibercept in Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
    Dhoot, Dilsher Singh
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [43] One-Year Follow Up Results of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema (DME) in Highly Treated Eyes
    Dhawlikar, Nisha
    Shah, Sumit P.
    Yarian, David L.
    Prenner, Jonathan
    Friedman, Eric S.
    Wheatley, H. Matthew
    Fine, Howard F.
    Mantopoulos, Dimosthenis
    Roth, Daniel B.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [44] COST EFFECTIVENES ANALYSIS OF RANIBIZUMAB COMPARED TO AFLIBERCEPT AND LASER INTERVENTION IN TREATMENT OF DIABETIC MACULAR EDEMA (DME) IN THE CZECH REPUBLIC
    Klimes, J.
    Regnier, S. A.
    Mahon, R.
    Budek, T.
    Dostal, F.
    Skalicky, D.
    Depta, J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A419 - A419
  • [45] Baseline Factors Influencing Resolution of Diabetic Macular Edema (DME) Following Treatment with Intravitreal Dexamethasone Implant in the MEAD Study
    Talcott, Katherine
    Valentim, Carolina Carvalho Soares
    Lai, Hongxin
    Ogidigben, Miller J.
    Singh, Rishi P.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [46] Results of a Phase I Study of Intravitreal VEGF Trap in Subjects with Diabetic Macular Edema: The Clear-It DME Study
    Do, D. V.
    Nguyen, Q. D.
    Browning, D. J.
    Shah, S. M.
    Chu, K.
    Buskey, J.
    Grimes, I.
    Ingerman, A.
    Cedarbaum, J. M.
    Campochiaro, P.
    [J]. PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, : 13 - +
  • [47] Primary Results from Two Phase 3 Trials of Faricimab for Diabetic Macular Edema (DME): YOSEMITE and RHINE
    Hu, Allen
    Willis, Jeffrey R.
    Haskova, Zdenka
    Silverman, David
    Ives, Jane
    Basu, Karen
    Lin, Hugh
    [J]. DIABETES, 2021, 70
  • [48] Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME)
    Byun, Matthew
    Riemann, Christopher D.
    Osher, James
    Patel, Yogin
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [49] Therapeutic response of patients with Diabetic macular edema (DME) with micropulsed yellow laser 577nm and intravitreal bevacizumab
    Rios, Geovanni Jassiel
    Rojas, Sergio
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [50] Prognostic factors in the treatment of diabetic macular edema (DME) using aflibercept, ranibizumab and bevacizumab (DRCR.net protocol T)
    Schmidt-Erfurth, Ursula
    Bogunovic, Hrvoje
    Schlegl, Thomas
    Sadeghipour, Amir
    Waldstein, Sebastian M.
    Gerendas, Bianca
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
12345